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Background
Abnormalities of dystrophin expression cause Duchenne
Muscular Dystrophy (D) or Becker Muscular Dystrophy
(B). Since widespread use of non-invasive respiratory ven-
tilation, many D patients who previously died in their
early 20 s from respiratory failure are now surviving
longer and developing cardiomyopathy. In B patients, dis-
ease progression is slower, however, development of pro-
gressive cardiomyopathy is highly frequent. One
previously identified predictor of mortality in cardiomy-
opathy is myocardial fibrosis as detected by late gadolin-
ium enhacement (LGE) cardiovascular magnetic
resonance (CMR) imaging. Furthermore, a high percent-
age and typical inferolateral pattern of LGE has been pre-
viously reported in small numbers of patients with B/D,
however, the relationship with left ventricular systolic
dysfunction needs to be further evaluated.
Methods and Results
In this two center study, 25 patients (median age 40 yrs,
range 11 to 60) with skeletal muscle biopsy and/or genet-
ically detected dystrophin abnormalities were prospec-
tively recruited from the Division of Cardiology of the
Robert-Bosch-Krankenhaus, Stuttgart, Germany and the
John Radcliffe Hospital, Oxford, UK. CMR was performed
using either a Siemens Magnetom Sonata 1.5-T (Erlangen,
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Short axis slice showing LGE in the lateral and inferolateral wallsFigure 1
Short axis slice showing LGE in the lateral and infero-
lateral walls. The unaffected reion in the septum provided 
the reference pont for LGE quantitative analysis.Page 1 of 2
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Germany) or 3-T Siemens Tim Trio (Erlangen, Germany).
Anatomical, functional and LGE imaging with quantifica-
tion of LGE extent (Figure 1) were performed.
Median left ventricular ejection fraction (LVEF) was 62%
(range 27 to 71%). LVEF was normal (? 60%) in 14/25
patients (median LVEF 66%, range 61 to 71%) and
reduced in 11/25 patients (median LVEF 43%, range 27 to
57%). LGE was present in 19/25 patients (median LGE/
total mass 17%, range 0 to 38%). Presence of LGE was
observed in 10/11 patients with reduced but also in 9/14
patients with normal LVEF (p = 0.60). The median size of
total LGE was higher for patients with reduced LVEF
(median LGE 17.4%, range 0 to 38%) compared to those
with normal LVEF (median LGE 11.9%, range 0 to 31%),
however, this trend was not statistically significant (p =
0.18). In patients with reduced LVEF (< 60%), there was a
subtle trend towards a decreased LVEF with increased LGE
extent (r2 = 0.28, Figure 2).
Conclusion
Myocardial fibrosis is present in most patients with B/D.
There is a subtle association between the extent of myocar-
dial fibrosis and impaired LVEF. Myocardial fibrosis in B/
D with normal LVEF suggests that fibrosis is either an early
disease manifestation or that other factors are required
before progression to dilated cardiomyopathy.
%LGE in patients with reduced LVEF (< 60%)Figure 2
%LGE in patients with reduced LVEF (< 60%).Page 2 of 2
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